//
Singapore-headquartered biotech start-up RWDC Industries announced today that it has successfully closed a US$13 million Series A2 round co-led by venture capital firms Vickers Venture Partners and WI Harper Group. Finance firm Ridgevale Enterprises Limited and individual investors also participated in the round. Series A2 funds will primarily be used to expand RWDC’s PHA (polyhydroxyalkanoate) […]
from Startups – Tech in Asia https://ift.tt/2PqWI7t